These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21625425)

  • 1. Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum.
    Costanzo MS; Brown KM; Hartl DL
    PLoS One; 2011; 6(5):e19636. PubMed ID: 21625425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum.
    Reynolds MG; Roos DS
    J Biol Chem; 1998 Feb; 273(6):3461-9. PubMed ID: 9452469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
    Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
    Malar J; 2011 May; 10():119. PubMed ID: 21554743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast.
    Cortese JF; Plowe CV
    Mol Biochem Parasitol; 1998 Aug; 94(2):205-14. PubMed ID: 9747971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.
    Delfino RT; Santos-Filho OA; Figueroa-Villar JD
    Biophys Chem; 2002 Aug; 98(3):287-300. PubMed ID: 12128181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
    Mkulama MA; Chishimba S; Sikalima J; Rouse P; Thuma PE; Mharakurwa S
    Malar J; 2008 May; 7():87. PubMed ID: 18495008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
    Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
    Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
    Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
    Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
    Santos-Filho OA; de Alencastro RB; Figueroa-Villar JD
    Biophys Chem; 2001 Jul; 91(3):305-17. PubMed ID: 11551441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
    Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
    Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
    Biswas S
    Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
    Sirawaraporn W; Sathitkul T; Sirawaraporn R; Yuthavong Y; Santi DV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1124-9. PubMed ID: 9037017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil.
    Vanichtanankul J; Taweechai S; Uttamapinant C; Chitnumsub P; Vilaivan T; Yuthavong Y; Kamchonwongpaisan S
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3928-35. PubMed ID: 22526319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation.
    Kiara SM; Okombo J; Masseno V; Mwai L; Ochola I; Borrmann S; Nzila A
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3793-8. PubMed ID: 19528269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates.
    Kreutzfeld O; Tumwebaze PK; Byaruhanga O; Katairo T; Okitwi M; Orena S; Rasmussen SA; Legac J; Conrad MD; Nsobya SL; Aydemir O; Bailey JA; Duffey M; Cooper RA; Rosenthal PJ
    J Infect Dis; 2022 Feb; 225(4):696-704. PubMed ID: 34460932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic pyrimethamine-resistant plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug.
    Posayapisit N; Pengon J; Prommana P; Shoram M; Yuthavong Y; Uthaipibull C; Kamchonwongpaisan S; Jupatanakul N
    Int J Parasitol; 2021 Jul; 51(8):635-642. PubMed ID: 33713651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.